Sponsor:
Dartmouth-Hitchcock Medical Center
Code:
NCT05529264
Conditions
Epilepsy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Memory Tasks
Attention/arousal tasks
Language tasks
Visuospatial tasks
Auditory Tasks
Brief summary:
Conditions
Epilepsy
Study ID
NCT05529264
Start date
Jan 17, 2023
Status verified date
Jan, 2026
Completion date
Aug 1, 2032
Anticipated
Primary completion date
Aug 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
175 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Basic Science
Arms
experimental: Invasive EEG (electrodes are implanted in a participant's brain)
experimental: Scalp EEG (electrodes are placed on a participant's scalp)
active comparator: Normal Controls
active comparator: Online Controls
Interventions
Memory Tasks
Attention/arousal tasks
Language tasks
Visuospatial tasks
Auditory Tasks
Brain Stimulation
Social Emotional Task
Recording of facial expressions
Judgement/Impulsivity Task
Primary outcome measure
Central contacts
Locations
Dartmouth-Hitchcock Medical Center
Recruiting
Lebanon, New Hampshire, United States, 03776
Contacts
Principal Investigator:
Krzysztof A Bujarski, MD
Sponsor
Dartmouth-Hitchcock Medical Center
Last update posted
Jan 15, 2026
Last verified
Jan, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center on 2026-01-15.